<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0587248" disease_type="Disease or Syndrome" abbrv="">Costello syndrome</z:e> was delineated based on its distinctive phenotype including <z:hpo ids='HP_0001525'>severe failure-to-thrive</z:hpo> with <z:hpo ids='HP_0000256'>macrocephaly</z:hpo>, characteristic facial features, <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo>, <z:e sem="disease" ids="C0030354" disease_type="Neoplastic Process" abbrv="">papillomata</z:e>, <z:mp ids='MP_0002018'>malignant tumors</z:mp>, and <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Heterozygous germline mutations in the proto-oncogene HRAS cause <z:e sem="disease" ids="C0587248" disease_type="Disease or Syndrome" abbrv="">Costello syndrome</z:e>, and its <z:hpo ids='HP_0000005'>inheritance</z:hpo> pattern would thus be <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>With exception of two instances of parental mosaicism, one presumed gonadal and the other proven <z:hpo ids='HP_0001442'>somatic mosaicism</z:hpo> for the p.G12S change, <z:hpo ids='HP_0000001'>all</z:hpo> published cases resulted from de novo mutations, typically arising in the paternal germline </plain></SENT>
<SENT sid="3" pm="."><plain>More than 90% of these mutations affect the <z:chebi fb="0" ids="29947">glycine residues</z:chebi> in position 12 or 13, and result in a gain-of-function of the altered protein </plain></SENT>
<SENT sid="4" pm="."><plain>A rare heterozygous HRAS alteration (c.173C &gt; T; p.T58I) associated with an attenuated phenotype was previously reported in one patient </plain></SENT>
<SENT sid="5" pm="."><plain>We identified two additional individuals with this mutation, father and son </plain></SENT>
<SENT sid="6" pm="."><plain>Further studies supported origin of the alteration in the grand-paternal germline </plain></SENT>
<SENT sid="7" pm="."><plain>Transmission of the mutation underscores its attenuated phenotype compatible with reproduction </plain></SENT>
<SENT sid="8" pm="."><plain>We reviewed the phenotype in the newly identified individuals (Patient 1, 2) and include updated information on the first previously reported individual with HRAS p.T58I (Patient 3) </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000256'>Macrocephaly</z:hpo> was present in <z:hpo ids='HP_0000001'>all</z:hpo> three </plain></SENT>
<SENT sid="10" pm="."><plain>Cardiac findings included <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> with <z:mp ids='MP_0010424'>double-chambered right ventricle</z:mp>; or <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> in one patient each </plain></SENT>
<SENT sid="11" pm="."><plain>While subtle <z:hpo ids='HP_0000707'>neurologic abnormalities</z:hpo> or <z:hpo ids='HP_0001263'>developmental delay</z:hpo> were present in <z:hpo ids='HP_0000001'>all</z:hpo>, only one showed significant cognitive and functional impairment </plain></SENT>
<SENT sid="12" pm="."><plain>None developed <z:e sem="disease" ids="C0030354" disease_type="Neoplastic Process" abbrv="">papillomata</z:e> or a <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignant tumor</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Genetic counseling for <z:e sem="disease" ids="C0587248" disease_type="Disease or Syndrome" abbrv="">Costello syndrome</z:e> needs to take into consideration the particular HRAS mutation </plain></SENT>
</text></document>